Gold Intraday: Gathering Upside Momentum

From a technical point of view, spot gold is gathering upside momentum as it may have formed a rounding bottom as shown on the 1-hour chart...

Gold 1

On Monday, spot gold gained 0.8% to $1,957 as the U.S. dollar eased. Reuters reported that AstraZeneca's Covid-19 vaccine trial in the U.S. remains on hold as regulators are still examining the serious side effect on the British patient. Earlier, the pharmaceutical giant said it has resumed clinical trials in the U.K..

Meanwhile, the Federal Reserve is expected to keeps its dovish tone after its FOMC meeting mid-week.

From a technical point of view, spot gold is gathering upside momentum as shown on the 1-hour chart. It may have formed a rounding bottom pattern, with prices trending to test the upper boundary of its recent consolidation range. The level at $1,937 may be considered as the nearest support, while the 1st and 2nd resistance are expected to be located at $1,974 and $1,992. Alternatively, a break below $1,937 would suggest that the next support at $1,920 may be challenged.

Source: Gain Capital, TradingView

Build your confidence risk free

More from Gold

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.